Avatrombopag for Adults with Early Versus Chronic Immune Thrombocytopenia

被引：0
|
作者：
Virk, Zain [1 ]
Leaf, Rebecca Karp [2 ]
Kuter, David J. [3 ,4 ]
Goodarzi, Katayoon [2 ]
Connell, Nathan T. [4 ,5 ]
Connors, Jean M. [6 ]
Al-Samkari, Hanny [4 ,7 ]
机构：
[1] Vanderbilt Univ, Dept Med, Med Ctr, Nashville, TN USA
[2] Massachusetts Gen Hosp, Boston, MA USA
[3] Massachusetts Gen Hosp, Div Hematol, Boston, MA USA
[4] Harvard Med Sch, Boston, MA USA
[5] Brigham & Womens Hosp, Div Hematol, Dept Med, Boston, MA USA
[6] Dana Farber Canc Inst, Boston, MA USA
[7] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179601
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Platelet Response to Avatrombopag in Patients with Chronic Immune Thrombocytopenia: Additional Analyses from a Phase 3 Study and Its Extension
    Nagalla, Srikanth
    Vredenburg, Michael
    Tian, Wei
    Allen, Lee F.
    BLOOD, 2019, 134
  • [42] Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China
    Wang, Zhifa
    Zhang, Aijun
    Xu, Zhongjin
    Wang, Nan
    Zhang, Jialu
    Meng, Jinxi
    Dong, Shuyue
    Ma, Jingyao
    Hu, Yu
    Ouyang, Juntao
    Chen, Zhenping
    An, Qi
    Cheng, Xiaoling
    Wu, Runhui
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (05) : 1958 - 1965
  • [43] Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study
    Kuter, David J.
    Bussel, James B.
    Ghanima, Waleed
    Cooper, Nichola
    Gernsheimer, Terry
    Lambert, Michele P.
    Liebman, Howard A.
    Tarantino, Michael D.
    Lee, Michelle
    Guo, Hailing
    Daak, Ahmed
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [44] Primary immune thrombocytopenia in adults: clinical practice versus management guidelines
    Ng, Thomas
    Gatt, Alex
    Smith, Mark
    POSTGRADUATE MEDICAL JOURNAL, 2017, 93 (1105) : 645 - 646
  • [45] Phase 2 study of avatrombopag in Japanese patients with chronic liver disease and thrombocytopenia
    Eguchi, Yuichiro
    Takahashi, Hirokazu
    Mappa, Silvia
    Santagostino, Elena
    HEPATOLOGY RESEARCH, 2022, 52 (04) : 371 - 380
  • [46] Cost-Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease
    Allen, Lee F.
    Aggarwal, Kavita
    Vredenburg, Michael
    Barnett, Christine
    Mladsi, Deirdre
    Kim, Ray
    BLOOD, 2019, 134
  • [47] Avatrombopag (Doptelet®) enriches therapeutic Spectrum in chronic Immune Thrombocytopenia First oral TPO-RA without Food Restrictions
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (12)
  • [48] Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease
    Mladsi, Deirdre
    Barnett, Christine
    Aggarwal, Kavita
    Vredenburg, Michael
    Dieterich, Douglas
    Kim, Ray
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 515 - 526
  • [49] RITUXIMAB SALVAGE THERAPY IN ADULTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA: EFFICACY AND SAFETY
    Reboursiere, E.
    Fouques, H.
    Maigne, G.
    Gac, A. C.
    Chantepie, S.
    Reman, O.
    Macro, M.
    Johnson, H.
    Benabed, K.
    Troussard, X.
    Cheze, S.
    HAEMATOLOGICA, 2014, 99 : 470 - 470
  • [50] Elevated NKT cell levels in adults with severe chronic immune thrombocytopenia
    Xu, Ruilong
    Zheng, Zhaojing
    Ma, Yongjun
    Hu, Yingping
    Zhuang, Shunhong
    Wei, Bin
    Lu, Jianxing
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (01) : 149 - 154
12345